Mail-order drug delivery surges amid pandemic
(By Katie Adams for Becker’s Hospital Review) Patients are increasingly opting for prescription drug delivery services instead of in-person pharmacy visits
Read More
Part D/Prescription Drugs
Could the drug supply chain be in danger?
The prescription drug supply chain is vulnerable even without a pandemic, as the industry is so dependent on international suppliers
Read MoreMedicare Advantage or Medigap
There are four parts of Medicare and then there is Medigap. Traditional Medicare Part A and B cover hospital services,
Read MoreThe U.S. government contributed research to a Gilead remdesivir patent — but didn’t get credit
(By Ed Silverman for STAT) Two documents dating back to 2015 shed further light on the role the federal government
Read MoreA basic review of the four parts of Medicare
Medicare provides coverage to Americans who are 65 or older regardless of income, medical history or health status. Medicare provides
Read MoreDrug transport costs jump 224% amid COVID-19 pandemic, survey finds
(By Katie Adams for Becker’s Hospital Review) The cost of shipping pharmaceuticals to the U.S has increased by an average
Read MoreGilead signals steps to widen global access to remdesivir for Covid-19 patients
(By Ed Silverman for STAT) Amid questions about access to remdesivir, its treatment for Covid-19, Gilead Sciences (GILD) says it
Read MoreIs $4,460 per course of treatment a fair price to treat COVID-19?
Gilead has not yet set a price for the first coronavirus treatment to have shown clinical benefits; however, the Institute
Read MoreDo formulary exclusion list benefit the patient?
Express Scripts and CVS Caremark, the two largest pharmacy benefit managers, increased the numbers of drugs on their 2020 exclusion
Read MoreCost of cancer drugs not linked to clinical benefit, study finds
(By Maia Anderson for Becker’s Hospital Review) The costs of dozens of cancer drugs were about 2.3 times higher in the
Read More